What is RER (Rapid Eye Movement)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Rapid Eye Movement Sleep Behavior Disorder (RBD) is a parasomnia characterized by abnormal or disruptive behaviors emerging during rapid eye movement (R) sleep, having the potential to cause injury or sleep disruption, and is typically diagnosed using polysomnography (PSG) showing loss of normal electromyographic (EMG) atonia. RBD is usually presented after the age of 50, though any age group can be affected, with a predilection for male gender, and prevalence estimates are 0.38% to 0.5% in the general population 1. The disorder can be idiopathic or secondary, related to neurodegenerative disorders, other neurologic disorders, sleep disorders, or medications, including withdrawal states, and appears to be associated with the α-synucleinopathies, such as Parkinson disease (PD), dementia of Lewy body (DLB) type, and multiple system atrophy (MSA) 1. Some key features of RBD include:

  • Abnormal behaviors during R sleep, such as talking, laughing, shouting, gesturing, grabbing, flailing arms, punching, kicking, and sitting up or leaping from bed
  • Loss of normal EMG atonia, manifest as either or both sustained muscle activity during R sleep in the chin EMG and excessive transient muscle activity (phasic muscle twitches) in either the chin or limb EMG
  • Risk of sleep-related injury (SRI), with between 33% and 65% of RBD patients reported to have had sleep-related injury to self or bed partner 1. The diagnosis and management of RBD should prioritize the prevention of sleep-related injuries and the treatment of underlying associated conditions, such as α-synucleinopathies, and should be guided by the most recent and highest quality evidence, such as the 2010 best practice guide for the treatment of RBD 1.

From the Research

Definition and Explanation of RER

  • The Respiratory Exchange Ratio (RER) is a measure of the ratio of total carbon dioxide produced over total oxygen consumed by an organism 2.
  • It serves as a qualitative measure to determine the substrate usage of a particular organism on the whole body level 2.
  • RER can be used to estimate the percentage of glucose and lipid oxidation at a given timepoint 2.

Factors Influencing RER

  • Muscle glycogen content, training volume, proportion of type 1 fibers, free fatty acid and lactate levels, and dietary fat intake are major determinants of resting RER 3.
  • During exercise, the key determinants of RER vary with intensity, including blood-borne substrate, muscle substrate, glycolytic enzyme activities, and lactate levels 3.
  • Resting RER is also a significant determinant of RER at low to moderate exercise intensities 3.

Measurement and Interpretation of RER

  • RER can be measured using indirect calorimetry, which provides a non-invasive estimate of substrate utilization 2.
  • Nonprotein respiratory quotient tables can be used to convert RER values into estimates of glucose and lipid oxidation, but these tables have limitations 2.
  • A new mathematical model has been developed to provide a more accurate and straightforward approach to converting continuous RER values into estimates of glucose and lipid oxidation 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Quantitative interpretation and modeling of continuous nonprotein respiratory quotients.

American journal of physiology. Endocrinology and metabolism, 2025

Research

Determinants of the variability in respiratory exchange ratio at rest and during exercise in trained athletes.

American journal of physiology. Endocrinology and metabolism, 2000

Related Questions

What is the interpretation of the alveolar-arterial (A-a) oxygen gradient?
What are the breathing treatments for lung disease beyond inhalers, corticosteroids, and nebulizers (nebulized therapy)?
Is Non-Invasive Positive Pressure Ventilation (NIPPV) or Continuous Positive Airway Pressure (CPAP) helpful in asthmatic patients in the prehospital setting?
Can individuals with chronic lung diseases undergo pulmonary rehabilitation?
What constitutes an emergency for a 7-month-old infant who fell 2.5 feet (approximately 0.76 meters) onto their face while landing in a prone position, cried, but now appears to be asymptomatic?
What is the significance of a myocardial perfusion imaging study showing moderate ischemia in the mid to distal Left Anterior Descending (LAD) artery territory?
What laboratory tests can help rule out Non-Hodgkin's Lymphoma (NHL) in a patient with a family history of the disease, specifically a brother diagnosed with Non-Hodgkin's Lymphoma (NHL)?
What are the implications of significantly elevated Creatine Kinase (CK) levels, greater than 60,000?
What is the comparison between betamethasone valerate (0.05% cream) and mometasone furoate (0.1% liquid) in terms of strength?
How does elexacaftor (ELEX)/ivacaftor (IVA)/tezacaftor (TEZ) compare to dual cystic fibrosis transmembrane conductance regulator (CFTR) modulators like ivacaftor (IVA)/tezacaftor (TEZ), ivacaftor (IVA)/lumacaftor (LUM), and ivacaftor (IVA) in terms of efficacy and safety in patients with cystic fibrosis (CF)?
Which nerve root is responsible for dorsal extension of the foot?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.